MacroGenics
MGNX
#9350
Rank
NZ$0.26 B
Marketcap
NZ$4.15
Share price
4.95%
Change (1 day)
63.32%
Change (1 year)

MacroGenics (MGNX) - Total assets

Total assets on the balance sheet as of June 2026 : NZ$0.61 Billion

According to MacroGenics's latest financial reports the company's total assets are NZ$0.61 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

MacroGenics - Total assets on balance sheet (from 2012 to 2024)

Total assets by year

Year Total assets Change
2023-12-31NZ$0.47 B6.82%
2022-12-31NZ$0.44 B-10%
2021-12-31NZ$0.49 B-6.5%
2020-12-31NZ$0.52 B13.12%
2019-12-31NZ$0.46 B-6.29%
2018-12-31NZ$0.49 B-5.95%
2017-12-31NZ$0.52 B17.16%
2016-12-31NZ$0.44 B-14.4%
2015-12-31NZ$0.52 B136.53%
2014-12-31NZ$0.22 B44.99%
2013-12-31NZ$0.15 B134.28%
2012-12-31NZ$65.33 M-18.65%
2011-12-31NZ$80.31 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Pfizer
PFE
NZ$358.29 B 58,129.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$263.77 B 42,768.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$170.37 B 27,588.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$87.93 B 14,190.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$231.22 B 37,479.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$158.13 B 25,600.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
NZ$1.29 B 109.88%๐Ÿ‡บ๐Ÿ‡ธ USA